Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
Clinical trial NCT06387121 · RECRUITING
Trial details
- NCT number
- NCT06387121
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2026-12-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.